United Kingdom · Research startup

Refeyn

Refeyn is an innovative company founded in 2018 as a spinout from Oxford University, specializing in mass photometry.

Funding reportedLast round: Series A

ResearchOxford, United Kingdom

About Refeyn

Refeyn is an innovative company founded in 2018 as a spinout from Oxford University, specializing in mass photometry.

This bioanalytical technology allows for the precise measurement of single molecules in their native, unlabeled state in solution. Headquartered in Oxford, UK, with additional offices in the US, Europe, Asia, and Japan, Refeyn aims to make its technology accessible to the global scientific community. The company's flagship product, the Refeyn mass photometer, is a compact analytical device designed for rapid mass analysis. It features automated software for efficient data processing and is capable of detecting molecular masses of single particles. Refeyn's technology is widely used in the life sciences sector, particularly in academic institutions and biopharmaceutical companies, for applications such as vector analytics, protein-protein interactions, and antibody aggregation analysis. With a strong focus on innovation, Refeyn is transforming biomolecular characterization and advancing bioanalytics.

What company datasets say Refeyn raised

Funding, as reported

Reported in all30Min the source's currency
Rounds2
Last roundSeries A
Last round size30M
Last round dateNov 2020
Investors listed6

Funding filed with regulators

Refeyn filed one raise, $214K in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. Jul 2026$214KUK share allotment

On a portfolio page

Investors who name them

Each firm lists Refeyn on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

The company, in detail

What they build

Known for

health carebiotherapeutic developmentbiotechnology researchsingle molecule measurementmass calibration standardsoligomeric state determinationcalibrantselectromedicalgmp compliancerapid dilution microfluidicscapsid loading analysislabel-free analysishospital & health carebiomolecular analyticsmedicalprotein-protein interactions

Built with from their website

Azure DevopsQtAtlassianOpticStudioPositGitHubGemCSSLiDARAtlassian Confluence

+8 more

ETQ Reliance QMSLinkedIn LearningPyTorchApple Business ManagerNetSuiteKnowBe4Twilio SendGrid Email Marketing CampaignsSourceTree

Sector
Research
Industry code
NAICS 541714, 334516, SIC 3824
Region
England
Revenue
26M a year, as listed
Full record
Every detail in the company directory

Research in United Kingdom

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Refeyn in front of investors. Or tell us what we have wrong.